FLORIDA PHARMACEUTICAL PRODUCTS, INC., INKS AGREEMENT WITH QILU TO MARKET AND DISTRIBUTE TENOFOVIR 300MG TABLETS

Boca Raton, FL (March 15, 2019) – Florida Pharmaceutical Products, Inc. (FPP) and Qilu Pharmaceutical Co., Ltd., (Qilu)., two pharmaceutical companies involved in the development manufacturing, sales, marketing and distribution of generic pharmaceuticals announce an agreement for FPP to manage sales, marketing and distribution of Qilu’s ANDA for Tenofovir 300mg Tablets. The product has current […]

FLORIDA PHARMACEUTICAL PRODUCTS, INC. AND QUINN PHARMACEUTICALS, LLC ANNOUNCE STRATEGIC ALLIANCE

Deal Combines Strengths of Both Companies Creating End-To-End Solution From Procurement to Order Fulfillment; Capitalizing On Opportunities Originating in Asia For U.S. Distribution (Boca Raton, FL and Irvine, CA; February 4, 2019) — Stason Pharmaceuticals, Inc., a global pharmaceutical group based in Irvine, CA has entered into a strategic alliance with Florida Pharmaceutical Products, Inc., […]

FLORIDA PHARMACEUTICAL PRODUCTS, INC. ANNOUNCES FDA SUBMISSION OF ANDA

Boca Raton, FL and Coimbra, Portugal (January 9, 2019) – Florida Pharmaceutical Products, Inc., also known as ‘FPP’ (www.flpharmaproducts.com) and Bluepharma Indústria Farmacêutica, S.A. (www.bluepharmagroup.com), two pharmaceutical companies involved in development, sales, marketing and distribution of generic pharmaceuticals are pleased to announce the signing of an agreement for development and licensing of an ANDA to […]